Uncovr, a surgical AI startup based in New York and Paris, has raised $7M in seed funding to turn the video from an operation into its official written record. The round was led by Index Ventures. Seedcamp, Frst, No Label Ventures, and Entrepreneurs Fi…
The British government has put its most contentious health-tech contract on notice. It is now formally reviewing the NHS’s £330mn deal with Palantir, and weighing whether to walk away in 2027. Technology minister Liz Kendall confirmed the review this w…
The NHS does not lack for AI pitches. What it has lacked is one that keeps patient data inside the country. A British software firm says it now has it. OneAdvanced, the Birmingham-based SaaS company whose software touches more than 40 million NHS patie…
Controlling a machine with your mind used to be science fiction. Now it is a regulated medical product, at least in China. Earlier this year, China’s National Medical Products Administration approved NEO, a coin-sized brain-computer interface developed…
America’s hospitals are spending around $97bn a year renting staff they cannot train fast enough. Stepful thinks AI can fix the supply side, and investors have just handed it $55mn to try. The New York startup has raised a Series C led by healthcare-an…
Reid Hoffman is stepping down from Microsoft‘s board of directors after nearly a decade. The company disclosed the departure in a regulatory filing on Thursday. Hoffman said he wants to go “founder mode” with Manus, his AI-powered drug discovery startu…
The Cambridge clinic has regulatory approval to triage, treat and discharge patients without a human in the loop. Now it wants to do the same for hip, knee and pelvic-health conditions. The unusual thing about Flok Health is not that an AI runs a physi…
Verily, the health and life sciences subsidiary of Google parent Alphabet, has asked the US Environmental Protection Agency for permission to release up to 64 million lab-bred mosquitoes across Florida and California over two years. The proposal, submi…
Akeso, the Chinese biotechnology company whose drug ivonescimab was dubbed “biotech’s DeepSeek moment” last year, has reported phase three clinical trial results showing a 34% reduction in the risk of death for patients with advanced squamous non-small…
HeartFocus, the AI-powered cardiac imaging software developed by French medtech company DESKi, has launched HeartFocus Link, a product that connects a tablet to any cart-based ultrasound system through a simple HDMI setup. The tablet runs HeartFocus’s …